Skip to main content

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

Identificación de factores de riesgo en el Trastorno por Déficit de Atención con Hiperactividad (TDAH) a través del estudio del perfil de metilación de ADN a escala genómica

IP: Marta Ribases Haro
Collaborators: Montserrat Corrales De la Cruz, ROSA M BOSCH MUNSO, Iris Garcia Martínez, Vanesa Richarte Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 122815
Reference: PI14/01700
Duration: 01/01/2015 - 31/12/2018

Identification of biomarkers for Attention Deficit/Hyperactivity Disorder (ADHD): Analysis of microRNA expression profiles (miRNA trascriptome) through high-throughput next generation sequencing

IP: Marta Ribases Haro
Collaborators: -
Funding agency: Brain & Behavior Research Foundation
Funding: 58581.84
Reference: BMADHD_NARSAD2014
Duration: 15/01/2015 - 14/01/2018

MiND: Mastering skills in the training Network for attention deficit hyperactivity and autism spectrum Disorders

IP: José Antonio Ramos Quiroga
Collaborators: Marta Ribases Haro
Funding agency: EUROPEAN COMMISSION
Funding: 100194.48
Reference: MIND_H2020-MSCA-ITN2013
Duration: 01/01/2015 - 31/12/2018

Psiquiatria, Salut Mental i Addicions (GRC)

IP: Miquel Casas Brugué
Collaborators: Núria Gómez Barros, Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, José Antonio Ramos Quiroga, ROSA M BOSCH MUNSO, Lara Grau Lopez, Iris Garcia Martínez, Marta Ribases Haro, Raquel Vidal Estrada, Vanesa Richarte Fernández, Francisco Collazos Sanchez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 27000
Reference: 2014 SGR 1357
Duration: 01/01/2014 - 31/12/2016

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The new drug improves core symptoms of depression in just three days

This new method improves and streamlines drug development processes

Related professionals

Melek Denizli

Melek Denizli

Research technician
Biomedical Research in Gynaecology
Read more
Julian Brandariz

Julian Brandariz

Research technician
Read more
Karla patricia Rojas Cuotto

Karla patricia Rojas Cuotto

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Elisa Carenza

Elisa Carenza

Predoctoral researcher
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.